Why Is ClearPoint Neuro ($CLPT ) Stock Down -21.62% Today? (Find out why any stock moved today on Tickeron.) CLPT shares fell approximately 21.62% on Tuesday, sliding from a prior close of $15.31 to about $12.00. The sell-off was triggered by disappointing 48-month clinical data from gene therapy partner uniQure, whose Huntington's disease candidate missed statistical significance on a key endpoint. ClearPoint Neuro supplies the MRI-guided navigation platform and SmartFlow cannula used to deliver uniQure's AMT-130 therapy, making the stock highly sensitive to its partner's trial outcomes. $ICUI $ISRG $A $NVST
published
Why Is ClearPoint Neuro ($CLPT ) Stock Down -21.62% Today? (Find out why any stock moved today on Tickeron.) CLPT shares fell approximately 21.62% on Tuesday, sliding from a prior close of $15.31 to about $12.00. The sell-off was triggered by disappointing 48-
$CLPT$ICUI$ISRG$A$NVST
Latest documented BWB result
$TSLA · $SPY market result
Exit $TSLA PDS with a .60 profit per contract - was willing to hold if $SPY closed under the SMA 50 but not with a close above it
Historical results are not a promise of future performance. Trading involves substantial risk.This public post is a timestamped information archive, not personalized financial advice. Alerts can change as markets move. Join Billy's private group for the complete daily stream and follow-through.